Intent to Sole Source -Blood Flow Restriction Unit

The Department of the Air Force Air Mobility Command has issued a Special Notice regarding an intent to sole source a Blood Flow Restriction Unit through the 763d Enterprise Sourcing Squadron at Pope AAF, North Carolina. The notice specifically targets the procurement of the Delfi Personalized Tourniquet System (model 9-2200-200BFR) manufactured by Owens Recovery Science, which is currently the only FDA-approved system using doppler micro processing for maintaining safe pressures during blood flow restriction training and rehabilitation. The notice falls under NAICS code 423450 for Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers, with a small business size standard of 500 employees. This sole source procurement method indicates the government has determined this specific device meets their unique requirements in a way that alternative products cannot.

Interested contractors have until 1:00 PM EST on December 13, 2024, to submit their capabilities and demonstrate why competition would benefit the government or provide comparable alternative models. The notice explicitly states this is not a competitive proposal solicitation, and no solicitation document will be made available. Potential vendors must provide clear, substantive evidence of their ability to meet or exceed the specifications of the Delfi system if they wish to challenge the sole source designation. No reimbursement will be provided for submitting capability information, and contractors must carefully review the attached documentation to understand the precise requirements. The opportunity is open to small businesses that meet the 500-employee size standard, with the primary goal of procuring a specialized medical device for blood flow restriction training and rehabilitation purposes within the Air Mobility Command.